Webinar on the use of platform technologies in the non-clinical and clinical domains, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 March 2026, 09:25 (CET) to 2 March 2026, 12:15 (CET)

Webinar on the use of platform technologies in the non-clinical and clinical domains, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 March 2026, 09:25 (CET) to 2 March 2026, 12:15 (CET)

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness